Advancing Treatment in Bullous Pemphigoid: A Comprehensive Review of Novel Therapeutic Targets and Approaches

HC Chen, CW Wang, WH Toh, HE Lee… - Clinical Reviews in …, 2023 - Springer
Bullous pemphigoid is one of the most common autoimmune bullous diseases occurring
primarily in the elderly. Pathogenic autoantibodies against BP180 and BP230 at the dermal …

Advancements in bullous pemphigoid treatment: a comprehensive pipeline update

M Karakioulaki, K Eyerich, A Patsatsi - American Journal of Clinical …, 2024 - Springer
Bullous pemphigoid (BP) is a common autoimmune bullous disease affecting mainly the
elderly, with rising incidence due to increased life expectancy. This disease is characterized …

Research progress of omalizumab in the treatment of bullous pemphigoid

X Ling, X Shou, Y Lou, J Ling, M Zhang… - The Journal of …, 2023 - Wiley Online Library
Bullous pemphigoid (BP) is an autoimmune blistering disease associated with anti‐BP180
and anti‐BP230 antibodies. The pathogenic action mechanism of immunoglobulin E (IgE) …

Autoimmunization against collagen XVII in patients with high risk for bullous pemphigoid and the effect of vildagliptin on the mouse skin proteome

A Nätynki - 2024 - oulurepo.oulu.fi
Bullous pemphigoid (BP) is an autoimmune blistering skin disease characterized by intense
itching and tense fluid-filled bullae and erythema located typically on the trunk and …

Correlation between nuclear expression of heat shock protein 90 in dermis and glucocorticoid resistance in bullous dermatosis

H Huang, W Wang, Y Cui, CX Hu, M Du - Steroids, 2023 - Elsevier
Background bullous dermatosis is a group of skin diseases that occur on the skin and
mucous membrane, with blister and bulla as basic damage, mainly including pemphigus …

Efficacy of omalizumab for the treatment of bullous pemphigoid: Spanish multicentre real-world experience

Á Aguado Vázquez… - Clinical and …, 2024 - academic.oup.com
Background Bullous pemphigoid (BP) is the most common autoimmune blistering disease.
Most patients are older and have associated multiple comorbidities. Topical and systemic …

[HTML][HTML] Bullous pemphigoid—What do we know about the most recent therapies?

FAP Zeng, DF Murrell - Frontiers in Medicine, 2022 - frontiersin.org
Introduction Bullous pemphigoid (BP) is the most common subtype of autoimmune blistering
diseases that primarily affects the elderly and is classically defined by the presence of IgG …